Abstract Submission
The call for abstracts is open with the deadline of Friday 12 June 2015. Please ensure you refer to the abstract guidelines outlined on the conference website.
Step-by-step instructions, including submission guidelines, an abstract template are outlined on the conference website, however if you require assistance, or have any concerns about the abstract submission process, please contact the Conference Secretariat at info@inhsu2015.com
Speaker Highlight
Alessio Aghemo received his medical degree from the University of Milan in 2001, where he also specialized in gastroenterology and later completed his post-doctoral research in gastroenterology. Dr. Aghemo holds the position of professor at the post-graduate school of gastroenterology and since 2013 is on the governing board of EASL.
Sponsor Spotlight
Gilead Sciences, a research-based biopharmaceutical company, discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation,and serious respiratory and cardiovascular conditions. Founded in 1987 in Foster City,California, Gilead now employs approximately 7,000 people in offices across five continents. In just over 25 years, Gilead has become a leading biopharmaceutical company with a rapidly expanding product portfolio and a growing pipeline of investigational drugs. Millions of people around the world are living healthier, more fulfilling lives because of innovative therapies developed by Gilead.
Registration
Register online before Friday 21 August 2015 to receive the early bird registration rate. For more information on registration types and rates, accommodation, as well as how to register, please visit the conference website. You can also download your copy of the registration brochure here.
Conference program viewable here.
Full details can be found on the Conference website or contact the Conference Secretariat on +61 2 8204 0770 or info@inhsu2015.com
